Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn’s Disease Commencing Biological Therapy: The Motility Study
Inflammatory Bowel Diseases · 01.09.2025 · 31 (9) · 2438-2450
DOI: 10.1093/ibd/izaf023 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 07.03.2025. Verfasst von Andrew A Plumb und 55 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University College London Hospitals, London, UK. Hauptthemen laut MEDLINE: Crohn Disease, Magnetic Resonance Imaging, Cine, Gastrointestinal Motility, Intestine, Small. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute for Health Research.
Abstract (Originalsprache)
Background
Small bowel Crohn’s disease (SBCD) is increasingly treated with biological therapies. Predicting response or remission (RoR) for individual patients is difficult and complicates treatment strategy. We aimed to determine if motility magnetic resonance imaging (mMRI) is superior to CRP and fecal calprotectin (FC) for the prediction of RoR at 1 year in patients commencing biologics for SBCD.
Methods
Prospective, multicenter (n = 13) cohort study of patients with active non-stricturing SBCD requiring anti-TNFα or anti-IL-12/23 treatment. We measured mMRI and CRP at baseline and post-induction (visit 2: 12-30 weeks), and FC in a subset. RoR was assessed at 1 year using clinical and structural magnetic resonance enterography parameters. We compared sensitivity, specificity, and area under the receiver operating characteristic curve (ROC-AUC) of changes in mMRI and CRP to predict RoR at 1 year. Secondary outcomes compared mMRI with FC, and prediction of improved quality of life (QoL).
Results
Eighty-six participants completed all assessments. Stable or improved mMRI at visit 2 was more sensitive than normalization of CRP for RoR (mMRI:71.0%, 95%CI 52.0-85.8; CRP:45.2%, 95%CI 27.3-64.0%, P = .008) but less specific (mMRI:30.9%, 95%CI 19.1-44.8; CRP:67.3%, 95%CI 53.3-79.3%, P < .001). There was no significant difference in ROC-AUC (mMRI:0.48; CRP:0.53, P = .65). Similar results were obtained for FC. None of mMRI, CRP, or FC predicted patient QoL at 1 year.
Conclusions
Although improved mMRI is more sensitive than CRP and FC to predict RoR at 1 year, it is less specific. No factor predicted patient QoL. Motility MRI remains a marker of disease activity at given timepoints.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, University College London Hospitals, London, UK.
- Centre for Medical Imaging, Division of Medicine, University College London, London, UK.
- Queen's Medical Centre, University of Nottingham, Nottingham, UK.
- Comprehensive Clinical Trials Unit, University College London, London, UK.
- Department of Gastroenterology, Royal Devon and Exeter Hospital, Exeter, UK.
- Department of Gastroenterology, University College London Hospitals, London, UK.
ORCID-Profile: Andrew A Plumb, Gordon Moran, Simon Travis, Shankar Kumar
Förderung
- National Institute for Health Research
Zitieren
APA
Plumb, A. A., Moran, G., Chowdhury, K., Ahmed, N., Philpott, S., Ahmad, T., Bloom, S., Hart, A., Jacobs, I., Menys, A., Mooney, P., Tolan, D., Travis, S., Bhagwanani, A., Bhatnagar, G., Boone, D., Franklin, J., Gangi-Burton, A., Hameed, M., …, & MOTILITY study co-authors (2025). Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn’s Disease Commencing Biological Therapy: The Motility Study. Inflammatory Bowel Diseases, 31(9), 2438-2450. https://doi.org/10.1093/ibd/izaf023
Vancouver
Plumb AA, Moran G, Chowdhury K, Ahmed N, Philpott S, Ahmad T, et al. Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn’s Disease Commencing Biological Therapy: The Motility Study. Inflammatory Bowel Diseases. 2025;31(9):2438-2450. doi:10.1093/ibd/izaf023
BibTeX
@article{Plumb2025,
author = {Plumb, Andrew A and Moran, Gordon and Chowdhury, Kashfia and Ahmed, Norin and Philpott, Sue and Ahmad, Tariq and Bloom, Stuart and Hart, Ailsa and Jacobs, Ilan and Menys, Alex and Mooney, Peter and Tolan, Damian and Travis, Simon and Bhagwanani, Anisha and Bhatnagar, Gauraang and Boone, Darren and Franklin, James and Gangi-Burton, Anmol and Hameed, Maira and Helbren, Emma and Hosseini-Ardehali, Faraz and Hyland, Rachel and Kilic, Yakup and Kumar, Shankar and Lambie, Hannah and Mohsin, Maryam and Patel, Anisha and Rahman, Safi and Sakai, Naomi and Sidhu, Harbir and Thomson, Elen and Ahmed, Saiam and Bannur Chikkeragowda, Uday and Barratt, Nina and Beeston, Teresita and Fitzke, Heather and Gibbons, Nicola and Godfrey, Edmund and Gupta, Arun and Higginson, Antony and Isaac, Elizabeth and Kok, Klaartje Bel and Langlands, Sarah and Parkes, Miles and Patel, Jaymin and Patel, Kamal and Patel, Kamini and Patodi, Nishant and Pollok, Richard and Przemiosolo, Robert and Robinson, Charlotte and Thoua, Nora and Wadke, Anvi and Halligan, Steve and Taylor, Stuart A and MOTILITY study co-authors, MOTILITY study co-authors},
title = {Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn’s Disease Commencing Biological Therapy: The Motility Study},
journal = {Inflammatory Bowel Diseases},
year = {2025},
volume = {31},
number = {9},
pages = {2438--2450},
doi = {10.1093/ibd/izaf023}
}
EUVIMED